Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Jörg Schilling"'
Autor:
Jörg Schilling, Pia Wülfing, Elisa Flahaut, Carsten Hielscher, Mark-Oliver Zahn, Dagmar Guth, Meinolf Karthaus, Gülten Oskay-Özcelik
Publikováno v:
Future Oncology. 16:939-953
Aim: To determine quality of life, effectiveness and safety of oral netupitant-palonosetron (NEPA)–based antiemetic prophylaxis in the real-world setting. Materials & methods: Prospective, noninterventional study in adults receiving highly or moder
Autor:
Jörg Schilling, Eberhard Müller, Steffi Busch, Andrea Stefek, Martin Holländer, Meinolf Karthaus, Jürgen Schwickerath, Falk Altmann
Publikováno v:
Cancer Research. 80:P2-12
Background: NEPA, an oral fixed dose combination of netupitant at 300 mg and palonosetron at 500 mg has been approved for the prevention of acute and delayed chemotherapy (Ctx)-induced nausea and vomiting (CINV) in cancer patients (pts) receiving hig
Autor:
Steffi Busch, C Hielscher, Jörg Schilling, Christian M. Kurbacher, Claus Hanusch, Meinolf Karthaus
Publikováno v:
Cancer Research. 79:P1-11
Background The oral fixed dose combination of netupitant and palonosetron NEPA has been approved for the prevention of acute and delayed chemotherapy-induced nausea and vomiting (CINV) in cancer patients receiving cisplatin-based highly emetogenic (H
Publikováno v:
Cancer Research. 78:P6-11
Background Inadequately controlled chemotherapy-induced nausea and vomiting (CINV) has a significant impact on the quality of life and daily functioning of cancer patients. Despite international antiemetic guidelines (ASCO, NCCN, MASCC/ESMO), CINV re
Autor:
Mark-Oliver Zahn, B Tschechne, A R Rotmann, Siegfried Haas, B. Gerber, Jörg Schilling, M Konias, Meinolf Karthaus, U Schwindel
Publikováno v:
Blood. 136:44-45
Introduction: Chemotherapy-induced nausea and vomiting (CINV) is a common and distressing side effect that has a detrimental impact on QoL. For pts receiving highly emetogenic chemotherapy (HEC), which includes those on anthracycline-cyclophosphamide
Publikováno v:
Cancer Research. 77:P2-11
Background Nausea and Vomiting due to cancer therapy is still a problem for patients and physicians and therefore an ongoing item of research in oncology. International antiemetic guidelines (ASCO, NCCN, MASCC/ESMO) have been published and new drugs
We present an experimental system suitable for producing spherical crystals and for observing the distribution of lattice defects (disclinations and dislocations) on a significant fraction (50%) of the sphere. The introduction of fluorescently labele
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7358d3486ffb232889dca06d10da203e
http://arxiv.org/abs/cond-mat/0506741
http://arxiv.org/abs/cond-mat/0506741